Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 19, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- January 17, 2007: Transfer of 80,759 Ordinary Shares.
- January 18, 2007: Transfer of 39,962 Ordinary Shares.
These transactions were advised to the Company on January 18 and January 19, 2007, respectively.
Management Commentary and Risks
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the shares held by the GSK Trust in the same capacity as other employees. No specific risks, contingencies, or unusual items beyond these standard trust transactions are disclosed.
Investor Verification Checklist
- Verify the total number of shares transferred from the GSK Trust to the Employee Share Option Plan (120,721 shares total).
- Confirm the specific dates of transfer (January 17 and 18, 2007) versus the dates the Company was advised (January 18 and 19, 2007).
- Review the status of the SmithKline Beecham Employee Share Option Plan 1991 to understand the vesting or exercise terms associated with these transfers.
- Note that this filing contains no financial performance data; refer to Form 20-F for annual financial results.